» Articles » PMID: 2429560

Fate of Pancreatic Enzymes During Small Intestinal Aboral Transit in Humans

Overview
Journal Am J Physiol
Specialty Physiology
Date 1986 Oct 1
PMID 2429560
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

To determine survival of pancreatic enzymes during small intestinal aboral transit in humans, seven healthy volunteers were intubated with an oroileal tube. By using nonabsorbable markers we measured the cumulative amount of lipase, trypsin, and amylase activities and lipase and trypsin immunoreactivities delivered postprandially to the duodenum, midjejunum, and terminal ileum. We found that as the enzymes moved from duodenum to ileum, 74% of amylase activity, 22% of trypsin activity, and 1% of lipase activity survived transit. Enzymatic activity and immunoreactivity of trypsin and lipase disappeared at different rates, suggesting that for these enzymes the sites of enzymatic activity and immunorecognition are not identical. Since tryptic activity is present even in the absence of immunorecognizable trypsin, complete structural integrity of the trypsin molecule may not be essential for its enzymatic activity. The short intraluminal survival of lipolytic activity may partially explain why patients with progressive exocrine pancreatic insufficiency malabsorb fat earlier than other nutrients.

Citing Articles

Identification and Characterization of Multiple Paneth Cell Types in the Mouse Small Intestine.

Timmermans S, Wallaeys C, Garcia-Gonzalez N, Pollaris L, Saeys Y, Libert C Cells. 2024; 13(17.

PMID: 39273007 PMC: 11394207. DOI: 10.3390/cells13171435.


Yield of testing for micronutrient deficiencies associated with pancreatic exocrine insufficiency in a clinical setting: An observational study.

Jalal M, Campbell J, Tesfaye S, Al-Mukhtar A, Hopper A World J Clin Cases. 2022; 9(36):11320-11329.

PMID: 35071562 PMC: 8717493. DOI: 10.12998/wjcc.v9.i36.11320.


Nanofibrous Formulation of Cyclodextrin Stabilized Lipases for Efficient Pancreatin Replacement Therapies.

Toth G, Kazsoki A, Gyarmati B, Szilagyi A, Vasvari G, Katona G Pharmaceutics. 2021; 13(7).

PMID: 34199011 PMC: 8308945. DOI: 10.3390/pharmaceutics13070972.


Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals.

Homayun B, Lin X, Choi H Pharmaceutics. 2019; 11(3).

PMID: 30893852 PMC: 6471246. DOI: 10.3390/pharmaceutics11030129.


Protease-Sensitive Pancreatic Lipase Variants Are Associated With Early Onset Chronic Pancreatitis.

Lasher D, Szabo A, Masamune A, Chen J, Xiao X, Whitcomb D Am J Gastroenterol. 2019; 114(6):974-983.

PMID: 30789418 PMC: 6624845. DOI: 10.14309/ajg.0000000000000051.